Sotera Health第三季度净利5800万美元：营收增长4.4%，重申全年指引
总部位于俄亥俄州 Cleveland 的医疗灭菌与实验室服务公司 Sotera Health（Nasdaq: SHC）11月3日公布2026年第三季度财报：季度净营收同比增长4.4%（固定汇率口径同为4.4%），净利5,800万美元、稀释每股收益0.20美元；调整后 EBITDA 同比增长3.9%，调整后每股收益0.29美元，同比增长12%。
分业务看，灭菌服务 Sterigenics 季度营收2.09亿美元，同比增长8.5%，分部利润1.17亿美元、增长9.6%；实验室服务 Nelson Labs 营收6,100万美元，增长8.8%；同位素业务 Nordion 营收5,500万美元，下降12.4%，主因钴-60收获时序的预期影响，分部利润率仍有改善。前九个月，Sterigenics 营收6.07亿美元、Nordion 1.46亿美元、Nelson Labs 1.73亿美元。
财务状况方面，公司季度经营活动现金流1.11亿美元；截至9月30日，总债务22亿美元，非受限现金与等价物4.12亿美元，净杠杆率由2025年底的3.2倍降至2.9倍，落在公司2.0至3.0倍的长期目标区间内；Moody's Ratings 于10月初上调了公司信用评级。首席执行官 Alton Shader 表示，季度业绩包括稳健的固定汇率营收与利润增长，调整后 EBITDA 利润率环比改善近100个基点至52.5%。
公司重申2026年全年指引：净营收12.33亿至12.50亿美元（固定汇率增长5.25%至6.75%），调整后 EBITDA 6.32亿至6.41亿美元（固定汇率增长5.75%至7.25%），调整后每股收益0.95至1.01美元，全年资本支出2.00亿至2.25亿美元。Sotera Health 为医疗行业提供灭菌解决方案、实验室检测与咨询服务，旗下包括 Sterigenics、Nordion 与 Nelson Labs 三个品牌。
（来源：Sotera Health）
Sotera Health Q3 Net Income Reaches $58 Million: Revenue Up 4.4%, Full-Year Outlook Reaffirmed
Sotera Health Company (Nasdaq: SHC), the Cleveland, Ohio-based sterilization and laboratory services provider, announced third-quarter 2026 results on November 3: net revenues increased 4.4% year over year on both a reported and constant-currency basis, net income was $58 million or $0.20 per diluted share, adjusted EBITDA increased 3.9%, and adjusted EPS was $0.29, up 12%.
By segment, Sterigenics net revenues rose 8.5% to $209 million with segment income up 9.6% to $117 million; Nelson Labs revenues rose 8.8% to $61 million; and Nordion revenues fell 12.4% to $55 million on the expected timing of Cobalt-60 harvest schedules, while its segment income margin improved. For the first nine months, Sterigenics revenues were $607 million, Nordion $146 million and Nelson Labs $173 million.
Net cash provided by operating activities was $111 million. As of September 30, the company had $2.2 billion of total debt and $412 million in unrestricted cash and cash equivalents, and its net leverage ratio improved to 2.9x from 3.2x at the end of 2025, within its long-term goal of 2.0x to 3.0x. Moody's Ratings upgraded the company's credit rating in early October. CEO Alton Shader said the quarter delivered solid constant-currency top- and bottom-line growth, with sequential adjusted EBITDA margin improving nearly 100 basis points to 52.5%.
The company reaffirmed its full-year 2026 outlook: net revenues of $1.233 billion to $1.250 billion (constant-currency growth of 5.25% to 6.75%), adjusted EBITDA of $632 million to $641 million (growth of 5.75% to 7.25%), adjusted EPS of $0.95 to $1.01, and capital expenditures of $200 million to $225 million. Sotera Health provides sterilization solutions, lab testing and advisory services to the healthcare industry through Sterigenics, Nordion and Nelson Labs.
(Source: Sotera Health)
来源：Sotera Health
发布：GSM·美国（发布链接）
图片来源：图：Sotera Health 总部所在地 Cleveland 市区天际线。Erik Drost 摄，CC BY 2.0，经 Wikimedia Commons。 / Photo: Downtown skyline of Cleveland, home of Sotera Health. Photo by Erik Drost, CC BY 2.0, via Wikimedia Commons.
GSM Global · 本篇英文版 English edition of this story